Startup | March 23, 2022
Glamyo Health, now available in 300 centres
The company is Series A funded with US $ 7 million in funding so far
The company is Series A funded with US $ 7 million in funding so far
This announcement comes after the formation of a new Intercontinental Region within GE Healthcare, led by Chaillot
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Data published in the prestigious journal ACS Central Science of the American Chemical Society
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
Subscribe To Our Newsletter & Stay Updated
